4.1 Aerosol Physics & Delivery Devices

4.1 Aerosol Physics & Delivery Devices

Aerosol medicine in neonatal and pediatric practice presents unique aerodynamic and developmental challenges. Infants and children are not miniature adults; their airway geometry, ventilatory patterns, and clinical tolerance radically alter the fraction of an aerosolized drug that reaches the lower respiratory tract. Mastering delivery physics, interface selection, and pharmacological agents is essential for the Neonatal/Pediatric Specialist.

---

Aerosol Physics & Pediatric Deposition Mechanics

Aerosol deposition within the human respiratory tract is governed by three primary physical mechanisms:

1. Inertial Impaction: Occurs when particles possess excessive momentum to negotiate curves in the airway and collide with mucosal surfaces. This mechanism predominates in particles with a Mass Median Aerodynamic Diameter (MMAD) $> 5\text{ }\mu\text{m}$, occurring primarily in the nasopharynx, oropharynx, and bifurcations of the large conducting airways where gas velocity is highest.
2. Gravitational Sedimentation: Occurs when aerosol droplets settle out of suspension under the influence of gravity during low-velocity airflow. This mechanism predominates for particles with an MMAD of $1\text{ to }5\text{ }\mu\text{m}$ within the smaller conducting airways and terminal bronchioles. Sedimentation is highly dependent on airway residence time and is enhanced by an inspiratory breath-hold.
3. Brownian Diffusion: The primary mechanism for ultra-fine particles (MMAD $< 0.5\text{ to }1.0\text{ }\mu\text{m}$) in the distal alveolar spaces where bulk gas flow ceases. Sub-micron particles undergo random collisions with gas molecules. However, particles $< 0.5\text{ }\mu\text{m}$ frequently remain suspended in gas and are exhaled before contacting alveolar walls.

Optimal Particle Sizing for Neonates and Children

The respirable fraction is commonly described as particles around $1\text{ to }5\text{ }\mu\text{m}$ MMAD, with deposition shifting by size, airway geometry, inhalation pattern, formulation, and device:

• Particles $> 5\text{ }\mu\text{m}$: Increasingly deposit in the mouth, nose, and larger conducting airways by impaction.
• Particles $3\text{ to }5\text{ }\mu\text{m}$: Favor central and conducting-airway deposition.
• Particles $1\text{ to }3\text{ }\mu\text{m}$: More readily penetrate toward smaller bronchi and distal regions, although submicron particles may remain suspended and be exhaled.

Developmental Barriers to Pediatric Aerosol Deposition

Infants receive a dramatically smaller percentage of the nominal nebulized dose than adults due to distinct physiological factors:

• Obligate Nasal Breathing: Up to 4 to 6 months of age, infants breathe preferentially through the nose. The tortuous nasal turbinates and narrow passages act as high-efficiency filters that remove up to 50% of aerosol particles before they reach the trachea.
• Low Tidal Volumes and High Deadspace: Neonatal tidal volumes ($V_T$) are small ($4\text{ to }6\text{ mL/kg}$), while the ratio of deadspace to tidal volume ($V_D / V_T$) is high. Only a small volume of aerosol-bearing gas enters the lungs with each breath.
• Rapid Respiratory Rates & Short Inspiratory Times ($T_I$): Neonates breathe at 30 to 60 breaths/min with $T_I$ as brief as $0.3\text{ to }0.5\text{ seconds}$. This brief inspiratory phase limits the time available for sedimentation, while rapid flow increases turbulent impaction at the glottis.
• Small Airway Diameters: By Poiseuille's law, resistance is inversely proportional to the fourth power of the radius ($R \propto 1/r^4$). Narrow infant airways promote premature impaction of droplets in proximal branches.

Infant lower-airway deposition is often a small fraction of the nominal dose, but the fraction changes substantially with the aerosol generator, interface, seal, breathing pattern, airway, and study method. Interpret device data rather than memorizing one percentage.

---

Aerosol Delivery Devices & Clinical Interfaces

Interface fit, aerosol generator, technique, breathing pattern, airway caliber, and adherence all influence pediatric aerosol delivery.

+------------------------------------------------------------------------------------------------+
|                                 AEROSOL GENERATOR COMPARISON                                   |
+-----------------------+-------------------------+---------------------+------------------------+
| Device Type           | Operating Mechanism     | Residual Dead Volume| Impact on Mechanical   |
|                       |                         |                     | Ventilation            |
+-----------------------+-------------------------+---------------------+------------------------+
| pMDI + Valved Holding | Metered dose canister;  | Negligible          | In-line chamber;       |
| Chamber (VHC)         | propellant vaporization |                     | zero added flow        |
+-----------------------+-------------------------+---------------------+------------------------+
| Small Volume Jet      | Pneumatic jet sheer;    | High (0.5–1.0 mL)   | Adds 6–8 L/min flow;   |
| Nebulizer (SVN)       | continuous flow gas     |                     | alters VT and triggers |
+-----------------------+-------------------------+---------------------+------------------------+
| Vibrating Mesh        | Piezoelectric aperture  | Minimal (< 0.1 mL)  | Zero added flow;       |
| Nebulizer (VMN)       | plate (100–130 kHz)     |                     | preserves vent settings|
+-----------------------+-------------------------+---------------------+------------------------+

1. Pressurized Metered-Dose Inhaler (pMDI) with Valved Holding Chamber (VHC)

A pMDI with a valved holding chamber and an age-appropriate snug mask or mouthpiece is an efficient, widely recommended bronchodilator-delivery method for many infants and children. Nebulizers remain appropriate in selected patients and settings; technique and cooperation often matter more than the device label.

• Mechanism of VHC: The holding chamber provides physical distance between the canister nozzle and the patient's mouth, allowing high-velocity propellant to evaporate, slowing the aerosol plume velocity, and reducing MMAD into the respirable range. The one-way inspiratory valve retains the aerosol cloud within the chamber until the child inhales, eliminating the requirement for hand-breath coordination.
• Mask seal: A leak around a pediatric mask can sharply reduce inhaled dose. Use the manufacturer's fit guidance, minimize dead space, and observe the valve or device indicator when available.
• The crying child: Crying produces an unfavorable inspiratory pattern and usually reduces lung delivery. Calm the child and use quiet tidal breathing when feasible; do not assume an exact percentage loss for every device.
• Blow-by technique: Dose falls rapidly as the interface moves away from the face, so blow-by is unreliable. Prefer a sealed, age-appropriate mask or mouthpiece unless a specific device has validated a different setup.

2. Vibrating Mesh Nebulizers (VMN)

Vibrating mesh nebulizers utilize a piezoelectric element vibrating at high frequency ($100\text{ to }130\text{ kHz}$) to pump liquid medication through thousands of laser-drilled micro-apertures in a dome-shaped aperture plate:

• Aerosol Characteristics: Generates uniform droplets with an MMAD of $1\text{ to }3\text{ }\mu\text{m}$ and high output rates ($> 0.2\text{ to }0.4\text{ mL/min}$).
• Low residual volume: Vibrating-mesh devices generally retain less medication than many jet nebulizers, though residual volume and emitted dose are device- and formulation-specific.
• Role in mechanical ventilation: A VMN does not add pneumatic driving flow. Placement strongly affects delivered dose and must follow the ventilator, nebulizer, humidifier, and medication instructions; circuit position is not interchangeable across systems.

3. Small Volume Jet Nebulizers (SVN)

Pneumatic jet nebulizers use a specified compressed-gas source and flow through a narrow capillary to draw liquid upward and break it against a baffle. Many small-volume devices operate near 6-8 L/min, but the required pressure and flow come from the device labeling.

• Dead Volume (Residual Volume): Jet nebulizers retain $0.5\text{ to }1.0\text{ mL}$ of liquid dead volume trapped inside the cup. Because a standard $2.5\text{ mg}$ albuterol unit dose contains only $3.0\text{ mL}$ of fluid, a residual volume of $1.0\text{ mL}$ traps $33%$ of the drug. Any added diluent, fill volume, and run time must follow the medication and nebulizer instructions; adding saline is not appropriate for every formulation or device.
• Mechanical-ventilation interaction: External jet-nebulizer flow can alter delivered volume, pressure, PEEP, triggering, and oxygen concentration, especially in a small patient. Use a ventilator-integrated or compensated setup when available and monitor the patient and measured ventilation during treatment.

---